ViewRay, Inc.
- Jurisdiction
United States - LEI
5493006XTUBSKFU3W106 - ISIN
US92672L1070 (VRAY )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. Read full profile
Stock price
Fundamentals
- Net revenue
€90.83M - Gross margin
8.0% - EBIT
-€92.21M - EBIT margin
-101.5% - Net income
-€97.96M - Net margin
-107.8%
Statement period: - (published )
Dividends
No dividend payouts
Earnings Calls
Latest earnings call: May 12, 2023